Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lieberman

Showing results (51-60 of 254) with videos related to

Pageof 26
Sort By:
Future Medicinal Chemistry|November 30, 2012
New direction for glaucoma therapeutics: focus on the olfactomedin domain of myocilinRebecca K Donegan, Raquel L Lieberman
Biochimica Et Biophysica Acta|February 13, 1986
Structure and action of heteronemertine polypeptide toxins. Specific cross-linking of Cerebratulus lacteus toxin B-IV to lobster axon membrane vesiclesD L Lieberman, K M Blumenthal
The American Journal of Medicine|January 4, 2014
Anaphylaxis: underdiagnosed, underreported, and undertreatedDavid A Sclar, Phillip L Lieberman
Plos One|February 2, 2011
Biophysical characterization of the olfactomedin domain of myocilin, an extracellular matrix protein implicated in inherited forms of glaucomaSusan D Orwig, Raquel L Lieberman
Developmental Biology|April 6, 2004
CK2 beta, which inhibits Mos function, binds to a discrete domain in the N-terminus of MosSoyan L Lieberman, Joan V Ruderman
Clinical Allergy and Immunology|August 16, 2000
Determining allergic versus nonallergic drug reactionsG D Marshall, P L Lieberman
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2007
From rhomboid function to structure and back againRaquel L Lieberman, Michael S Wolfe
Journal of Women'S Health|August 27, 1998
Cardiac rehabilitation: gender differences in factors influencing participationL Lieberman, M Meana, D Stewart
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2007
Membrane-embedded protease poses for photoshootRaquel L Lieberman, Michael S Wolfe
Journal of Medicinal Chemistry|September 11, 2015
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising DirectionsRebecca K Donegan, Raquel L Lieberman
Pageof 26

Showing results (51-60 of 254) with videos related to

Sort By:
Pageof 26
Future Medicinal Chemistry|November 30, 2012
New direction for glaucoma therapeutics: focus on the olfactomedin domain of myocilinRebecca K Donegan, Raquel L Lieberman
Biochimica Et Biophysica Acta|February 13, 1986
Structure and action of heteronemertine polypeptide toxins. Specific cross-linking of Cerebratulus lacteus toxin B-IV to lobster axon membrane vesiclesD L Lieberman, K M Blumenthal
The American Journal of Medicine|January 4, 2014
Anaphylaxis: underdiagnosed, underreported, and undertreatedDavid A Sclar, Phillip L Lieberman
Plos One|February 2, 2011
Biophysical characterization of the olfactomedin domain of myocilin, an extracellular matrix protein implicated in inherited forms of glaucomaSusan D Orwig, Raquel L Lieberman
Developmental Biology|April 6, 2004
CK2 beta, which inhibits Mos function, binds to a discrete domain in the N-terminus of MosSoyan L Lieberman, Joan V Ruderman
Clinical Allergy and Immunology|August 16, 2000
Determining allergic versus nonallergic drug reactionsG D Marshall, P L Lieberman
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2007
From rhomboid function to structure and back againRaquel L Lieberman, Michael S Wolfe
Journal of Women'S Health|August 27, 1998
Cardiac rehabilitation: gender differences in factors influencing participationL Lieberman, M Meana, D Stewart
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2007
Membrane-embedded protease poses for photoshootRaquel L Lieberman, Michael S Wolfe
Journal of Medicinal Chemistry|September 11, 2015
Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising DirectionsRebecca K Donegan, Raquel L Lieberman
Pageof 26